Palisade Bio Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$2.12

-0.03 (-1.40%)

As of Aug 18, 1:55 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 15 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +107.5% upside

Low Target $2.36

Average Target $4.40

High Target $4.89

Current Price $2.12

Current
$2.12

Target
$4.40

$2.36 $4.40 avg $4.89

Scenario Analysis

Bear Case

$2.36

11.3%

Low target

Base Case

$4.40

+107.5%

Avg target

Bull Case

$4.89

+130.7%

High target

Risk/Reward

11.5x

Highly favorable

Price in Context

52-Week High

$2.86

-25.7% from high

52-Week Low

$0.53

+300.0% from low

Target vs 52W High

$4.40

+54.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-0.5%
AMGN Amgen Inc	Hold	43	49%	$190.87	-55.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+152.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-17.0%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.5%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-54.1%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-47.2%
BIIB Biogen Inc	Buy	43	67%	$91.45	-57.0%